VanEck · 2011-12-20 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$1.6M | — | — | $406.9M | 每日估算 |
| 2026-07-30 | +$14.5M | — | — | $409.7M | 每日估算 |
| 2026-07-29 | -$10.7M | — | — | $397.9M | 每日估算 |
| 2026-07-28 | +$425,766 | — | — | $397.0M | 每日估算 |
| 2026-07-27 | -$1.4M | — | — | $395.6M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
Gilead Sciences Inc Gilead Sciences Inc | EC | 390,092 | $54.4M | 14.63% |
Amgen Inc Amgen Inc | EC | 153,582 | $54.0M | 14.54% |
Vertex Pharmaceuticals Inc Vertex Pharmaceuticals Inc | EC | 67,053 | $29.9M | 8.06% |
Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、nasdaq_etf_summary、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| 每日估算 |
| 2026-07-26 | +$896,969 | — | — | $397.9M | 每日估算 |
| 2026-07-25 | +$896,969 | — | — | $397.9M | 每日估算 |
| 2026-03-31 | +$364,508 | $25.8M | $25.4M | $371.6M | SEC 月度 |
| 2026-02-28 | -$1.9M | $1.9M | $3.9M | — | SEC 月度 |
| 2026-01-31 | +$69,037 | $2.0M | $1.9M | — | SEC 月度 |
| EC |
| 36,132 |
| $27.9M |
| 7.51% |
Argenx SE Argenx SE | EC | 26,852 | $19.6M | 5.28% |
Insmed Inc Insmed Inc | EC | 104,290 | $17.1M | 4.59% |
IQVIA Holdings Inc IQVIA Holdings Inc | EC | 93,651 | $16.0M | 4.30% |
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc | EC | 46,120 | $15.3M | 4.11% |
Natera Inc Natera Inc | EC | 73,931 | $14.8M | 3.98% |
United Therapeutics Corp United Therapeutics Corp | EC | 23,856 | $14.1M | 3.81% |
Biogen Inc Biogen Inc | EC | 75,443 | $13.8M | 3.72% |
BeOne Medicines Ltd BeOne Medicines Ltd | EC | 40,622 | $12.1M | 3.25% |
Moderna Inc Moderna Inc | EC | 226,910 | $11.5M | 3.10% |
Revolution Medicines Inc Revolution Medicines Inc | EC | 109,365 | $10.6M | 2.86% |
Illumina Inc Illumina Inc | EC | 75,133 | $9.3M | 2.49% |
Incyte Corp Incyte Corp | EC | 88,766 | $8.4M | 2.25% |
BioNTech SE BioNTech SE | EC | 90,077 | $8.0M | 2.15% |
Neurocrine Biosciences Inc Neurocrine Biosciences Inc | EC | 54,628 | $7.2M | 1.94% |
BioMarin Pharmaceutical Inc BioMarin Pharmaceutical Inc | EC | 91,597 | $5.2M | 1.39% |
Bio-Techne Corp Bio-Techne Corp | EC | 95,803 | $5.0M | 1.35% |
Charles River Laboratories International Inc Charles River Laboratories International Inc | EC | 27,539 | $4.8M | 1.28% |
ICON PLC ICON PLC | EC | 42,718 | $4.7M | 1.27% |
QIAGEN NV QIAGEN NV | EC | 106,309 | $4.3M | 1.15% |
Tempus AI Inc Tempus AI Inc | EC | 76,175 | $3.4M | 0.93% |
State Street Navigator Securities Lending Government Money Market Portfolio State Street Navigator Securities Lending Government Money Market Portfolio | STIV | 853,193 | $853,193 | 0.23% |